Zeidan Ahed, Kassem Rida, Nahleh Nazih, Maaliki Hilal, El-Khatib Mohamad, Struys Michel M R F, Baraka Anis
Department of Anesthesiology, Sahel General Hospital, Beirut, Lebanon.
Anesth Analg. 2008 Jul;107(1):292-9. doi: 10.1213/ane.0b013e31816ba364.
Intraarticular (IA) local anesthetics are often used for the management and prevention of pain after arthroscopic knee surgery. Recently, IA tramadol was also used for the management of these patients. However, the IA combination of local anesthetic and tramadol has not been evaluated in arthroscopic outpatients. Our primary aim in this study was to evaluate the analgesic effect of an IA combination of bupivacaine and tramadol when compared with each drug alone using visual analog scale (VAS) pain scores in patients undergoing day-care arthroscopic knee surgery. Additionally, we assessed analgesic demand.
Ninety ASA I/II patients undergoing arthroscopic partial meniscectomy, performed by a single surgeon under general anesthesia, were assigned in a randomized, double-blind manner into three groups: group B (n = 30) received 0.25% bupivacaine, group T (n = 30) received 100 mg tramadol, and group BT (n = 30) received 0.25% bupivacaine and 100 mg tramadol to a total volume of 20 mL by the IA route after surgery. Postoperative pain scores were measured on a VAS, at rest and on mobilization at 0.5, 1, 2, 4, 6, 8, 12, and 24 h. Duration of analgesia, the subsequent 24 h consumption of rescue analgesia, time to ambulation, and time to discharge were evaluated. In addition, the systemic side effects of the IA injected drugs were also assessed.
The results showed significantly lower VAS pain scores in group BT (P << 0.1) when compared with groups T and B. Group BT had a later onset of postsurgical pain and longer time to first rescue analgesic than groups B and T. The 24 h consumption of analgesic was significantly less in group BT when compared with the other two groups (26.7% of the patients required rescue analgesia in group BT, whereas this number was 90% in group B and 86.7% in group T). In addition, time in hours to discharge and time to unassisted ambulation were significantly shorter in group BT when compared with groups T and B, and this was not associated with any detectable systemic effects.
The IA admixture of tramadol 100 mg with bupivacaine 0.25% provides a pronounced prolongation of analgesia compared with either drug alone in patients undergoing day care arthroscopic knee surgery.
关节腔内(IA)局部麻醉药常用于膝关节镜手术后疼痛的管理和预防。最近,IA曲马多也被用于这些患者的治疗。然而,局部麻醉药与曲马多的IA联合应用在关节镜门诊患者中尚未得到评估。本研究的主要目的是,在日间膝关节镜手术患者中,使用视觉模拟量表(VAS)疼痛评分,比较布比卡因与曲马多IA联合应用与单独使用每种药物时的镇痛效果。此外,我们还评估了镇痛需求。
90例接受关节镜下部分半月板切除术的美国麻醉医师协会(ASA)I/II级患者,由一名外科医生在全身麻醉下进行手术,以随机、双盲的方式分为三组:B组(n = 30)接受0.25%布比卡因,T组(n = 30)接受100 mg曲马多,BT组(n = 30)在术后通过IA途径接受0.25%布比卡因和100 mg曲马多,总量为20 mL。术后在0.5、1、2、4、6、8、12和24小时,于静息和活动时用VAS测量疼痛评分。评估镇痛持续时间、随后24小时的补救镇痛消耗量、行走时间和出院时间。此外,还评估了IA注射药物的全身副作用。
结果显示,与T组和B组相比,BT组的VAS疼痛评分显著更低(P << 0.1)。BT组术后疼痛发作较晚,首次补救镇痛时间比B组和T组长。与其他两组相比,BT组24小时的镇痛消耗量显著更少(BT组26.7%的患者需要补救镇痛,而B组为90%,T组为86.7%)。此外,与T组和B组相比,BT组的出院时间和独立行走时间显著更短,且这与任何可检测到的全身影响无关。
在接受日间膝关节镜手术的患者中,100 mg曲马多与0.25%布比卡因的IA混合剂与单独使用任一药物相比,镇痛作用显著延长。